Condensed Consolidated Financial Statement Detail (Tables)
|
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2014
|
||||||||||||||||||||||||||||||||||||||||||||||
Condensed Consolidated Financial Statement Detail [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
Outstanding securities considered anti-dilutive |
The following table shows the total outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||
Accrued liabilities |
Accrued liabilities consisted of the following at March 31, 2014 and December 31, 2013 (in thousands):
|